Respiratory Medicine
Volume 97, Issue 1 , Pages 71-74 , January 2003

Bronchodilating effects of cumulative doses of formoterol from a novel multi-dose inhaler (Airmax®)

  • E.F.L DUBOIS

      Affiliations

    • Reinier de Graaf Groep, Delft-Voorburg, The Netherlands
    • ,
  • E RÖDER

      Affiliations

    • Reinier de Graaf Groep, Delft-Voorburg, The Netherlands
    • ,
  • R.G IFLÉ

      Affiliations

    • Volendam, The Netherlands

Received 20 December 2001 ,Accepted 17 May 2002.

References 

    REFERENCES
  1. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroids in asthma patients with symptoms on existing inhaled corticosteroids. Lancet. 1994;344:219–224
  2. Pauwels RA, Löfdahl CG, Postma DS. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med. 1998;337:15 405–15 411
  3. Juniper EF, Svensson K, O'Byrne PM. Asthma quality of life during one year of treatment with budesonide with or without formoterol. Eur Respir J. 1999;14:1038–1043
  4. Derom EY, Pauwels RA. Time course of bronchodilating effect of inhaled formoterol, a potent and long-acting sympathomimetic. Thorax. 1992;47:30–33
  5. Wallin A, Sandstrom T, Rosenhall L, Melander B. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax. 1993;48:611–614
  6. Zeng XM, O'Leary D, Phelan M, Jones S, Colledge J. Delivery of salbutamol and of budesonide from a novel multi dose inhaler Airmax®. Respir Med. 2002;96:404–411
  7. Zeng XM, Jones S, O'Leary D, Phelan M, Colledge J. Delivery of formoterol from a novel multi dose inhaler Airmax®. Respir Med. 2002;96:397–403
  8. Chew NY, Chan HK. In vitro aerosol performance and dose uniformity between the Foradil Aerolizer and the Oxis Turbuhaler. J Aerosol med. 2001;14:495–501
  9. Maesen F PV, Costongs R, Smeets SJ, Zweers P GMA, Goedhart DM. Formoterol as dry powder inhalation; a dose finding study in comparison with formoterol metered dose inhaler and placebo. Chest. 1992;101:1376–1381
  10. Ringdal N, Derom E, Wahlin-Boll E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler®. Respir Med. 1998;92:1017–1021
  11. Shenfield G, Paterson J. Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax. 1973;28:124
  12. Duncan D, Paterson I, Harris D, Crompton G. Comparison of the effects of salbutamol inhaled as a dry powder and by conventional pressurized aerosol. Br J Clin Pharmacol. 1977;4:669–671
  13. Foucard T, Lönnerholm G. A study with cumulative doses of formoterol and salbutamol in children with asthma. Eur Respir J. 1991;4:1174–1177
  14. Palmqvist M, Persson G, Lazer L, Rosenborg J, Larsson P, Lotvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Resp J. 1997;10:2484–2489
  15. Wallin A, Sandstrom T, Rosenhall L, Melander B. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax. 1993;48:611–614

PII: S0954-6111(02)91410-1

doi: 10.1053/rmed.2002.1410

Respiratory Medicine
Volume 97, Issue 1 , Pages 71-74 , January 2003

Article Tools